1. Introduction {#sec1-molecules-22-01140}
===============

*Mikania micrantha* H. B. K., belonging to the Asteraceae family, is a fast-growing perennial creeping vine indigenous to Central and South America. This plant is known as an invasive species in Southeast Asia and the Pacific region, including southern China \[[@B1-molecules-22-01140]\]. The rapid spread of *M. micrantha* in South China has caused great damage to agriculture and forestry, as well as the ecological balance in invaded areas \[[@B1-molecules-22-01140]\]. *M. micrantha* has long been used as a traditional herbal medicine in Jamaica to treat skin itches and athlete's foot \[[@B2-molecules-22-01140]\]. Previous phytochemical studies have reported some structurally diverse chemicals from this plant, including sesquiterpene lactones, flavonoids, steroids, diterpene glucosides, and phenolic compounds, some of which have shown significant bioactivities \[[@B3-molecules-22-01140],[@B4-molecules-22-01140],[@B5-molecules-22-01140],[@B6-molecules-22-01140],[@B7-molecules-22-01140],[@B8-molecules-22-01140],[@B9-molecules-22-01140],[@B10-molecules-22-01140],[@B11-molecules-22-01140],[@B12-molecules-22-01140]\]. Our recent study on this plant also revealed a group of rare C-9 hydroxylated *ent*-kaurene diterpene glucosides \[[@B13-molecules-22-01140]\]. During our ongoing phytochemical research on invasive plants in China \[[@B14-molecules-22-01140],[@B15-molecules-22-01140],[@B16-molecules-22-01140],[@B17-molecules-22-01140],[@B18-molecules-22-01140],[@B19-molecules-22-01140]\], two new (**1** and **2**) and twelve known (**3**--**14**) phenolic compounds ([Figure 1](#molecules-22-01140-f001){ref-type="fig"}), were further isolated from the aerial parts of *M. micrantha*. Herein, we report the isolation and structure elucidation of these compounds, as well as their antioxidant activity.

2. Results and Discussion {#sec2-molecules-22-01140}
=========================

Compound **1** was obtained as a colorless syrup and deduced to have the molecular formula C~20~H~22~O~9~ from its HR-ESI-MS data, *m*/*z* 441.0971 \[M + Cl\]^−^ (calcd for C~20~H~22~O~9~Cl^−^, 441.0958), which required ten degrees of unsaturation. The ^1^H and ^13^C-NMR spectra of **1** ([Table 1](#molecules-22-01140-t001){ref-type="table"}), coupled with HSQC analysis, indicated twenty carbons, including two methylenes, thirteen methines, and five quaternary carbons including one carboxyl group at δ~C~ 168.1 (C-7). The signals of δ~H~ 4.69 (1H, d, *J* = 7.6 Hz, H-1′′) and δ~C~ 60.6 (C-6′′), 69.6 (C-4′′), 73.2 (C-2′′), 77.0 (C-3′′), 76.5 (C-5′′), and 101.9 (C-1′′) indicated the presence of a β-[d]{.smallcaps}-glucopyranosyl moiety in the molecule. The presence of a benzyl moiety in the molecule was suggested by the proton signals at δ~H~ 7.49 (2H, m, H-2′, 6′), 7.42 (2H, m, H-3′, 5′), 7.37 (1H, m, H-4′), and 5.37 (2H, m, H-7′), and further supported by the carbon signals at δ~C~ 128.1 (C-2′, 6′), 128.6 (C-3′, 5′), 128.3 (C-4′), and 66.6 (C-7′). Besides, the presence of an ABX spin system was ascertained by the characteristic proton signals of two doublets at δ~H~ 6.94 (1H, d, *J* = 9.0 Hz, H-3) and 7.44 (1H, d, *J* = 3.1 Hz, H-6), a double doublet at δ~H~ 7.28 (1H, dd, *J* = 9.0, 3.1 Hz, H-4), and further confirmed by the ^13^C-NMR and HSQC spectra, which revealed three aromatic quaternary carbons at δ~C~ 112.9 (C-1), 155.3 (C-2), and 149.9 (C-5), and three aromatic methine carbons at δ~C~ 118.3 (C-3), 125.2 (C-4), and 117.0 (C-6). After a more carefully study of the aforementioned NMR data and taking into account the proposed molecular formula, it could be deduced that a free hydroxyl (OH) group would exist in the molecule. In the HMBC spectrum ([Figure 2](#molecules-22-01140-f002){ref-type="fig"}), correlation signals from δ~H~ 10.14 (OH-2) to δ~C~ 112.9 (C-1), 118.3 (C-3), and 155.3 (C-2) was observed, which revealed the position of the hydroxyl group at C-2. The observation of significant HMBC correlation from δ~H~ 4.69 (H-1′′) to δ~C~ 149.9 (C-5) verified the location of the glucopyranosyl moiety at C-5. The HMBC correlations from δ~H~ 6.94 (H-3) and 7.44 (H-6) to δ~C~ 168.1 (C-7) proved the connection of the carboxyl group to C-1. In addition, the ester bond linkage of C-7 with C-7′ was supported by the observation of significant HMBC correlation from δ~H~ 5.37 (H-7′) to δ~C~ 168.1 (C-7). Therefore, compound **1** was established as benzyl 5-*O*-β-[d]{.smallcaps}-glucopyranosyl-2,5-dihydroxybenzoate.

Compound **2**, obtained as a colorless oil, was determined to have the molecular formula C~22~H~26~O~9~ according to its HR-ESI-MS data, *m*/*z* 457.1467 \[M + Na\]^+^ (calcd for C~22~H~26~O~9~Na^+^, 457.1469), which required ten degrees of unsaturation. The ^1^H-NMR spectrum ([Table 1](#molecules-22-01140-t001){ref-type="table"}) showed signals of an acetoxy methyl at δ~H~ 2.02 (3H, s), two methoxy groups at δ~H~ 3.83 (3H, s) and 3.89 (3H, s), and five aromatic protons. The ^13^C-NMR spectrum ([Table 1](#molecules-22-01140-t001){ref-type="table"}), coupled with HSQC analysis, exhibited the signals of twenty-two carbons in total, comprising three methyls, two oxymethylenes \[δ~C~ 64.3 (C-9′) and 66.7 (C-9)\], nine methines (including five aromatic methanes), and eight quaternary carbons \[including a carboxyl group at δ~C~ 172.7 and seven aromatic quaternary carbons\]. Detailed analysis of the NMR data indicated that compound **2** closely resembled *threo*-dihydroxydehydrodiconiferyl alcohol \[[@B20-molecules-22-01140],[@B21-molecules-22-01140],[@B22-molecules-22-01140]\], with the only difference of the hydroxyl group at C-9 being replaced by an acetoxy group in **2**. This deduction was consistent with the molecular formula and in accord with the significant HMBC correlations ([Figure 2](#molecules-22-01140-f002){ref-type="fig"}) from δ~H~ 4.33 and 4.44 (C-9) to δ~C~ 172.7. The relative configuration of H-7 and H-8 was determined to be *trans*, as supported by the NOE correlations of H-7/H-9 and H-8/H-6, H-2 ([Figure 2](#molecules-22-01140-f002){ref-type="fig"}). The absolute configuration of C-7 and C-8 in **2** was assigned to be *S* and *R* based on the positive CD Cotton effects at 292 nm and 240 nm and the negative Cotton effect at 224 nm \[[@B23-molecules-22-01140],[@B24-molecules-22-01140]\]. Furthermore, according to literature reports about that the chemical shifts of the C-7′ and C-8′ and the value of ∆δ~C8′--C7′~ are characteristically different for the *threo* and *erythro* isomers, the relative configuration of C-7′ and C-8′ in **2** could then be determined to be *threo* based on its ^13^C-NMR data at δ~C~ 75.3 (C-7′) and 77.6 (C-8′) with the value of ∆δ~C8′--C7′~ \> 2.0 ppm \[[@B25-molecules-22-01140],[@B26-molecules-22-01140],[@B27-molecules-22-01140]\]. Hence, compound **2** was elucidated as (7*S*,8*R*)-*threo*-dihydroxydehydrodiconiferyl alcohol 9-acetate.

The twelve known compounds were identified as benzyl 2-*O*-β-[d]{.smallcaps}-glucopyranosyl-2,6-dihydroxybenzoate (**3**) \[[@B28-molecules-22-01140]\], 4-allyl-2,6-dimethoxyphenol glucoside (**4**) \[[@B29-molecules-22-01140]\], (+)-isolariciresinol (**5**) \[[@B30-molecules-22-01140]\], icariol A~2~ (**6**) \[[@B31-molecules-22-01140]\], 9,10-dihydroxythymol (**7**) \[[@B32-molecules-22-01140]\], 8,9,10-trihydroxythymol (**8**) \[[@B11-molecules-22-01140]\], caffeic acid (**9**) \[[@B33-molecules-22-01140]\], *p*-coumaric acid (**10**) \[[@B34-molecules-22-01140]\], ethyl protocatechuate (**11**) \[[@B35-molecules-22-01140]\], procatechuic aldehyde (**12**) \[[@B33-molecules-22-01140]\], 4-hydroxybenzoic acid (**13**) \[[@B36-molecules-22-01140]\], and hydroquinone (**14**) \[[@B37-molecules-22-01140]\] by comparison of their NMR and ESI-MS data with those reported in the literature. All the known compounds, except **8** and **9**, were isolated from this plant species for the first time.

All of the isolated compounds were measured for their antioxidant activity by using three different in vitro assays, i.e., ABTS radical cation (ABTS^•+^) scavenging assay, DPPH radical (DPPH^•^) scavenging assay, and FRAP assay, with [l]{.smallcaps}-ascorbic acid as a reference compound. As shown in [Table 2](#molecules-22-01140-t002){ref-type="table"}, new compounds **1** and **2**, and known compounds **3**, **9**, **10**, **13**, and **14** demonstrated ABTS radical cation scavenging activity with SC~50~ values ranging from 0.31 to 4.86 µM, which were more potent than [l]{.smallcaps}-ascorbic acid (SC~50~ = 10.48 µM). Compounds **5**, **9**, **11**, and **12** exhibited more potent DPPH radical scavenging activity (SC~50~ = 16.24--21.67 µM) than [l]{.smallcaps}-ascorbic acid (SC~50~ = 39.48 µM). Moreover, the revealed ferric reducing antioxidant power (FRAP) of compounds **2**, **5**, **9**, and **11** were also comparable to or even more potent than the reference compound.

Generally, free radicals and reactive oxygen species (ROS) are formed unceasingly in human body and the normal presence of free radicals can produce beneficial oxidation during physiological events. However, excessive generation of free radicals in human body will bring harmful oxidation to organisms, which is recognized as a leading cause of a variety of chronic diseases such as atherosclerosis, angiocardiopathy and cancer \[[@B38-molecules-22-01140],[@B39-molecules-22-01140]\]. It is well known that natural antioxidants can help prevent oxidation and help regulate immune function. This study, to some extent, indicate that the invasive plant *M. micrantha* is rich in structurally diverse natural antioxidants, at least in antioxidant phenolic compounds, which are potential functional chemicals beneficial for human health worthy of further investigation.

3. Materials and Methods {#sec3-molecules-22-01140}
========================

3.1. General Experimental Procedures {#sec3dot1-molecules-22-01140}
------------------------------------

Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker DRX-500 NMR spectrometer (Bruker Biospin Gmbh, Rheistetten, Germany). Electrospray ionization mass spectrometry (ESI-MS) was measured on a MDS SCIEX API 2000 LC/MS/MS apparatus (Applied Biosystems Inc., Forster, CA, USA). High-resolution (HR) ESI-MS was measured on a Bruker Bio TOF IIIQ spectrometer (Bruker Daltonics, Billerica, MA, USA). Optical rotations were obtained on a Perkin-Elmer Model 341 polarimeter (Perkin-Elmer, Inc., Waltham, MA). UV spectra were acquired on a Perkin-Elmer Lambda 650 UV-Vis spectrometer (Perkin-Elmer, Inc., Waltham, MA, USA). Preparative HPLC was performed with an HPLC system epuipped with a Shimadzu LC-6AD pump and a Shimadzu RID-10A refractive index detector using a Shim-pack PRC-ODS C-18 column (5 µm, 20 mm × 250 mm). Medium pressure liquid chromatography (MPLC) was carried out on a CXTH P3000 instrument (Beijing Chuang Xin Tong Heng Science and Technology Co., Ltd, Beijing, China) equipped with a UV 3000 UV-Vis Detector and a C-18 column (50 µm, 50 mm × 500 mm).

Silica gel (80--100 and 200--300 mesh, Qingdao Haiyang Chemical Co., Qingdao, China), and Sephadex LH-20 (Pharmacia Fine Chemical Co., Ltd., Oppsala, Sweden) were used for open column chromatography (CC). Thin-layer chromatography (TLC) was conducted on precoated silica gel plates (HSGF~254~, Yantai Jiangyou Silica Gel Development Co., Ltd., Yantai, China) and spot detection was performed by spraying 10% H~2~SO~4~ in ethanol, followed by heating. DPPH, ABTS and 2,4,6-Tripyridy-s-triazine (TPTZ) were purchased from Sigma-Aldrich (Shanghai) Trading Co. (Shanghai, China). Phosphate buffered saline (PBS) and [l]{.smallcaps}-ascorbic acid were obtained from Life technologies (Thermo Fisher Scientific, Shanghai, China) and Shanghai Boao Biotech Co. (Shanghai, China), respectively.

3.2. Plant Material {#sec3dot2-molecules-22-01140}
-------------------

The aerial parts of *M. micrantha* were collected from Guangzhou, China, in July 2014, and identified by Prof. Hong-Feng Chen, South China Botanical Garden, Chinese Academy of Sciences (CAS). A voucher specimen (No. 20140705) was deposited at the Laboratory of Bioorganic Chemistry of the South China Botanical Garden, CAS.

3.3. Extraction and Isolation {#sec3dot3-molecules-22-01140}
-----------------------------

Powdered air-dried aerial parts of *M. micrantha* (18.5 kg) were extracted three times (each time for three days) with 95% EtOH (50 L) at room temperature. The EtOH extract, after concentration in vacuo, was suspended in water (3 L) and then sequentially extracted three times each with petroleum ether (3 L) and EtOAc (3 L) to yield a petroleum ether-soluble fraction (520 g), and an EtOAc-soluble fraction (260 g) after condensation to dryness under vacuum. The EtOAc-soluble fraction was subjected to silica gel column chromatography, eluted with an increasing polarity of CHCl~3~/MeOH (from 98:2 to 70:30, *v*/*v*, each 18 L) to afford fractions E~1~--E~6~ after pooling according to their TLC profiles. Fraction E~3~ (20 g), obtained on elution with CHCl~3~/MeOH (95:5), was separated by MPLC using a decreasing polarity of MeOH/H~2~O (35:65--100:0, *v*/*v*, each 1 L) system at the flow rate of 8 mL/min to give fractions E~3-1~--E~3-20~. Fraction E~3-2~, obtained from the elution with MeOH/H~2~O (35:65), was applied on Sephadex LH-20 column chromatography with the elution of CHCl~3~/MeOH (1:4, *v*/*v*), to provide fractions E~3-2-1~--E~3-2-4~. E~3-2-4~ was purified by preparative HPLC with a Shim-pack PRC-ODS C-18 column (5 µm, 20 mm × 250 mm) using 10% acetonitrile in water (*v*/*v*) as a mobile phase at the flow rate of 8 mL/min to obtain **12** (9 mg, t~R~ = 78 min) and **6** (3 mg, t~R~ = 110 min). Fraction E~3-8~ was applied on LH-20 CC with the elution of CHCl~3~/MeOH (1:4, *v*/*v*) to furnish **5** (5 mg), and **10** (9 mg). Fraction E~4~ (18.8 g), obtained on elution with CHCl~3~/MeOH (95:5), was separated by MPLC using a decreasing polarity of MeOH/H~2~O (35:65--100:0, *v*/*v*, each 1 L) system at the flow rate of 8 mL/min to give fractions E~4-1~--E~4-18~. Fraction E~4-11~, obtained from the elution with MeOH/H~2~O (45:55), was applied on Sephadex LH-20 column chromatography with the elution of CHCl~3~/MeOH (1:4, *v*/*v*), to provide fractions E~4-11-1~--E~4-11-6~. The fraction E~4-11-3~ was further purified by preparative HPLC with a Shim-pack PRC-ODS C-18 column (5 µm, 20 mm × 250 mm) using 16% acetonitrile in water (*v*/*v*) as a mobile phase at the flow rate of 8 mL/min to obtain **2** (2 mg, t~R~ = 78 min). Fraction E~4-6~ was applied on LH-20 CC with the elution of CHCl~3~/MeOH (1:4, *v*/*v*) to furnish **7** (4 mg), **8** (18 mg), and **13** (27 mg). Fraction E~4-13~ was applied on LH-20 CC with the elution of CHCl~3~/MeOH (1:4, *v*/*v*) and then purified by HPLC using 16% acetonitrile in water (*v*/*v*) as mobile phase at 8 mL/min to furnish **4** (10 mg, t~R~ = 90 min) and **3** (13 mg, t~R~ = 100 min). Fraction E~5~ (18.6 g), obtained on elution with CHCl~3~/MeOH (90:10), was separated by MPLC using a decreasing polarity of MeOH/H~2~O (10:90--100:0, *v*/*v* , each 1 L) system at the flow rate of 8 mL/min to give fractions E~5-1~--E~5-30~. Fraction E~5-19~, obtained from the elution with MeOH/H~2~O (65:35), was applied on Sephadex LH-20 column chromatography with the elution of CHCl~3~/MeOH (1:4, *v*/*v*), to provide fractions E~5-19-1~--E~5-19-6~. The fraction E~5-19-6~ was further purified by preparative HPLC with a Shim-pack PRC-ODS C-18 column (5 µm, 20 mm × 250 mm) using 25% acetonitrile in water (*v*/*v*) as a mobile phase at the flow rate of 8 mL/min to obtain **1** (10 mg, t~R~ = 65 min). Fraction E~5-2~, was applied on LH-20 CC with the elution of CHCl~3~/MeOH (1:4, *v*/*v*) to furnish **9** (10 mg), **11** (5 mg), and **14** (3 mg).

*Benzyl 5-O-β-[d]{.smallcaps}-glucopyranosyl-2,5-dihydroxybenzoate* (**1**): Colorless syrup; \[α$\rbrack_{D}^{20}$ −22.50 (*c* 0.68, C~5~H~5~N); UV (C~5~H~5~N) λ~max~ nm (log *ε*) 251 (4.16), 257 (4.19); HR-ESI-MS *m*/*z* 441.0971 \[M + Cl\]^−^ (calcd for C~20~H~22~ClO~9~^−^, 441.0958); ^1^H-NMR (500 MHz) and ^13^C-NMR (125 MHz) data in DMSO-*d*~6~, see [Table 1](#molecules-22-01140-t001){ref-type="table"}.

*(7S,8R)-threo-Dihydroxydehydrodiconiferyl alcohol 9-acetate* (**2**): Colorless oil; \[α$\rbrack_{D}^{20}$ + 45.71 (*c* 0.07, MeOH); UV (MeOH) λ~max~ nm (log *ε*) 282 (3.70); HR-ESI-MS *m*/*z* 457.1467 \[M + Na\]^+^ (calcd for C~22~H~26~NaO~9~^+^, 457.1469); ^1^H-NMR (500 MHz) and ^13^C-NMR (125 MHz) data in CD~3~OD, see [Table 1](#molecules-22-01140-t001){ref-type="table"}.

3.4. Antioxidant Activity Evaluation {#sec3dot4-molecules-22-01140}
------------------------------------

### 3.4.1. ABTS Radical Cation Scavenging Assay {#sec3dot4dot1-molecules-22-01140}

The ABTS radical cation (ABTS^•+^) scavenging activity of the isolated compounds was evaluated following the procedures as previously described \[[@B40-molecules-22-01140]\]. Briefly, potassium persulfate was added to 7 mM of ABTS^•+^, and the mixture was allowed to stand in the dark at room temperature for 12--16 h before use. The ABTS^•+^ solution was diluted with phosphate-buffered saline (PBS, pH 7.4) to provide an absorbance of 0.70 ± 0.02 at 734 nm. The diluted ABTS^•+^ solution (190 μL) was added to sample fractions (10 μL) in DMSO at different concentrations. Each treatment was conducted in triplicate. After a mixing time of 10 s and an incubation period of 6 min at 37 °C in the dark, the absorbance in each well was read at 415 nm on a Genios microplate reader (Tecan). [l]{.smallcaps}-Ascorbic acid was used as a positive control. The inhibitory rates of ABTS^•+^ were calculated according to the following formula: ABTS scavenging rate (%) = \[1 − (absorbance of compound − absorbance of blank)/absorbance of control\] × 100. SC~50~ values were calculated and expressed as means ± SD in micromolar.

### 3.4.2. DPPH Radical Scavenging Assay {#sec3dot4dot2-molecules-22-01140}

Scavenging activity of the compounds towards DPPH radicals was carried out by the method as previously described \[[@B40-molecules-22-01140]\]. DPPH radical solution was freshly prepared with MeOH to 0.1 mM. Test compounds were dissolved in DMSO and diluted two-fold to six serial concentrations. The DPPH solution (180 μL) and sample solution (20 μL) were mixed in 96-well plates. [l]{.smallcaps}-Ascorbic acid was dissolved in methanol and used as a positive reference. The control group contained DMSO instead of the compound solution, and the blank group contained methanol in place of the DPPH solution. Each treatment was performed in quadruplicate. The plates were incubated at 37 °C for 30 min in the dark. The absorbance in each well was read at 515 nm on a Genios microplate reader (Tecan). The inhibitory rates of DPPH radicals were calculated according to the formula: DPPH scavenging rate (%) = \[1 − (absorbance of compound − absorbance of blank)/absorbance of control\] × 100. SC~50~ values (the concentrations required to scavenge 50% DPPH radicals present in the test solution) were calculated and expressed as means ± SD in micromolar.

### 3.4.3. FRAP Assay {#sec3dot4dot3-molecules-22-01140}

Ferric reducing ability of the compounds was conducted according to the procedures as previously described \[[@B40-molecules-22-01140]\]. FRAP reagent was made freshly by mixing 300 mM acetate buffer (pH 3.6), 10 mM TPTZ solution in 40 mM hydrochloric acid, and 20 mM aqueous ferric chloride (FeCl~3~) solution in a 10:1:1 (*v*/*v*) ratio. The TPTZ solution was prepared on the same day. Test compounds were dissolved in methanol and diluted 2-fold to six concentrations. Twenty microliters of the compound solution and 180 μL of FRAP reagent were mixed in 96-well plates. [l]{.smallcaps}-Ascorbic acid was dissolved in methanol and used as a positive reference. Each treatment was conducted in quadruplicate. The plates were incubated at 37 °C for 30 min in the dark. The absorbance of the product (ferrous TPTZ complex) in each well was read at 595 nm using a Genios microplate reader (Tecan Group, Mannedorf, Switzerland). One milliliter of ferrous sulfate (FeSO~4~) at six different concentrations and 1 mL of 10 mM TPTZ and 10 mL of 300 mM acetate buffer (pH 3.6) were used for a calibration curve. FRAP values were calculated and expressed as means ± the standard deviation (SD) in millimoles of Fe (II) per gram.

4. Conclusions {#sec4-molecules-22-01140}
==============

Fourteen phenolic compounds, including two new ones---**1** and **2**, were isolated from the aerial parts of *M. micrantha*. Their structures were identified by analysis of their spectroscopic data. Except **8** and **9**, all the other compounds were isolated from this plant species for the first time. Bioassays revealed that seven compounds demonstrated good ABTS radical cation scavenging activity more potent than [l]{.smallcaps}-ascorbic acid, and four compounds exhibited more potent DPPH radical scavenging activity than [l]{.smallcaps}-ascorbic acid. Moreover, the ferric-reducing antioxidant power (FRAP) of four compounds were comparable to or even more potent than L-ascorbic acid. This study indicates that the invasive plant *M. micrantha* is rich in structurally diverse phenolic compounds with functional potential beneficial for human health and is worthy of further investigation.
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molecules-22-01140-t001_Table 1

###### 

The ^1^H (500 MHz) and ^13^C (125 MHz) nuclear magnetic resonance (NMR) data of compounds **1** and **2**.

  ---------------------------------------------------------------------------------------------
  H/C    1 ^a^                   H/C            2 ^b^                            
  ------ ----------------------- -------------- -------- ----------------------- --------------
  1                              112.9 (C)      1                                133.8 (C)

  2                              155.3 (C)      2        6.96 (d, 1.9)           110.6 (CH)

  3      6.94 (d, 9.0)           118.3 (CH)     3                                149.2 (C)

  4      7.28 (dd, 9.0, 3.1)     125.2 (CH)     4                                147.8 (C)

  5                              149.9 (C)      5        6.79 (d, 8.1)           116.2 (CH)

  6      7.44 (d, 3.1)           117.0 (CH)     6        6.84 (dd, 8.1, 1.9)     120.0 (CH)

  7                              168.1 (C)      7        5.48 (d, 7.0)           89.7 (CH)

  1′                             135.6 (C)      8        3.76 (dd, 13.0, 7.0)    51.9 (CH)

  2′     7.49 (m)                128.1 (CH)     9        4.33 (dd, 11.1, 7.6)\   66.7 (CH~2~)
                                                         4.44 (dd, 11.1, 5.4)    

  3′     7.42 (m)                128.6 (CH)     1′                               137.3 (C)

  4′     7.37 (m)                128.3 (CH)     2′       6.98 (s)                112.9 (CH)

  5′     7.42 (m)                128.6 (CH)     3′                               145.4 (C)

  6′     7.49 (m)                128.1 (CH)     4′                               148.8 (C)

  7′     5.37 (m)                66.6 (CH~2~)   5′                               128.7 (C)

  1′′    4.69 (d, 7.6)           101.9 (CH)     6′       6.93 (s)                116.5 (CH)

  2′′    3.20 (m)                73.2 (CH)      7′       4.59 (d, 6.0)           75.3 (CH)

  3′′    3.24 (m)                77.0 (CH)      8′       3.68 (dd, 4.2, 6.0)     77.6 (CH)

  4′′    3.16 (m)                69.6 (CH)      9′       3.40 (dd, 11.1, 6.3)\   64.3 (CH~2~)
                                                         4.44 (dd, 11.1, 4.2)    

  5′′    3.24 (m)                76.5 (CH)      OMe-3    3.83 (s)                56.4 (CH~3~)

  6′′    3.48 (dd, 11.8, 3.5)\   60.6 (CH~2~)   OMe-3′   3.89 (s)                56.7 (CH~3~)
         3.63 (dd, 11.8, 6.0)                                                    

  OH-2   10.14 (s)                              OAc                              172.7 (C)

                                                         2.02 (s)                20.7 (CH~3~)
  ---------------------------------------------------------------------------------------------

^a^ Recorded in DMSO-*d*~6~; ^b^ Recorded in CD~3~OD.

molecules-22-01140-t002_Table 2

###### 

Antioxidant activity of compounds **1**--**14**.

  Compound                        ABTS (SC~50~, μM)   DPPH (SC~50~, μM)   FRAP (mmol/g)
  ------------------------------- ------------------- ------------------- ---------------
  **1**                           0.31 ± 0.02         \>100               0.54 ± 0.03
  **2**                           4.19 ± 0.05         \>100               12.28 ± 0.25
  **3**                           1.83 ± 0.07         \>100               1.01 ± 0.17
  **4**                           \>50                \>100               1.41 ± 0.15
  **5**                           9.40 ± 0.13         21.67 ± 2.27        13.12 ± 0.23
  **6**                           31.81 ± 0.17        34.24 ± 0.39        5.08 ± 0.08
  **7**                           \>50                \>100               0.05 ± 0.00
  **8**                           6.54 ± 0.07         \>100               1.13 ± 0.25
  **9**                           4.69 ± 0.19         16.24 ± 0.31        20.86 ± 0.24
  **10**                          3.48 ± 0.16         \>100               3.12 ± 0.05
  **11**                          18.23 ± 0.36        20.57 ± 0.29        10.87 ± 0.18
  **12**                          9.30 ± 0.01         16.59 ± 0.24        7.79 ± 0.12
  **13**                          4.86 ± 0.22         \>100               2.57 ± 0.07
  **14**                          4.57 ± 0.27         31.96 ± 1.24        8.77 ± 0.22
  [l]{.smallcaps}-ascorbic acid   10.48 ± 0.07        39.48 ± 0.38        11.32 ± 0.13

Each value represents mean ± standard deviation (n = 3).

[^1]: These authors contributed equally to this work.
